New class drug significantly reduces spine fracture risk in postmenopausal women with osteoporosis


The results of a study presented at the Annual European Congress of Rheumatology (EULAR) 2017 press conference showed that, in postmenopausal women with osteoporosis, 12 months treatment with romosozumab was associated with rapid and large reductions in their risk of a vertebral fracture compared to placebo...DEVAMI

Source:

En Çok Okunan Yazılar
En Son Yazılar
Arşiv

MENÜ

SOSYAL MEDYA

DR. TAMER TEKİN İLETİŞİM

Fevzi Çakmak Mahallesi, Tevfik İleri Cd No:105, Pendik, İstanbul


+90 216 397 5900

+90 541 539 5979

 
E-mail : info@drtamertekin.com

@ 2014 Tamer Tekin. Istanbul/Turkey. Tüm hakları saklıdır. YASAL UYARI: YAZILI İZİN OLMADAN KOPYALANAMAZ VE YAYINLANAMAZ.